Understanding the hepatitis B core positive liver donor

被引:2
作者
Kwan, Kah Wai Clarence [1 ,2 ]
Lim, Teegan Reina [1 ]
Kumar, Rajneesh [1 ,3 ]
Krishnamoorthy, Thinesh Lee [1 ,3 ]
机构
[1] Singapore Gen Hosp, Dept Gastroenterol & Hepatol, Outram Rd, Singapore 169608, Singapore
[2] Singapore Armed Forces Med Corps, Singapore, Singapore
[3] Duke NUS Med Sch, Singapore, Singapore
关键词
core positive donor; liver transplant; occult hepatitis B; viral reactivation; VIRUS INFECTION; TRANSPLANTATION; RECIPIENTS; LAMIVUDINE;
D O I
10.11622/smedj.2018104
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The increasing number of patients on the Singapore national liver transplant waiting list and the lack of donor livers have necessitated a review of the limited use of marginal donor liver grafts. Some grafts are of good quality but are considered marginal due to positive donor antibody to hepatitis B virus core protein serology, and negative hepatitis B surface antigen (HBsAg) and hepatitis B DNA. The fear is of viral reactivation during periods of intense immunosuppression. This is made possible by the ability of the hepatitis B virion to reside in a dormant state within the hepatocyte nucleus despite HBsAg clearance, i.e. the occult hepatitis B infection (OBI). In truth, appropriate selection of recipients and effective post-transplantation immunoprophylaxis significantly reduce the risk of hepatitis B viral reactivation. This article explains the confusion surrounding OBI and reviews current recommendations on how to manage such donor liver grafts.
引用
收藏
页码:545 / 549
页数:5
相关论文
共 26 条
[1]   Seroepidemiology of hepatitis B virus infection among adults in Singapore: A 12-year review [J].
Ang, Li Wei ;
Cutter, Jeffery ;
James, Lyn ;
Goh, Kee Tai .
VACCINE, 2013, 32 (01) :103-110
[2]   Hepatitis B virus replication [J].
Beck, Juergen ;
Nassal, Michael .
WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (01) :48-64
[3]   Prevention of De Novo Hepatitis B in Recipients of Core Antibody-Positive Livers With Lamivudine and Other Nucleos(t)ides: A 12-Year Experience [J].
Chang, Matthew S. ;
Olsen, Sonja K. ;
Pichardo, Elsa M. ;
Stiles, Jessica B. ;
Rosenthal-Cogan, Lori ;
Brubaker, William D. ;
Guarrera, James V. ;
Emond, Jean C. ;
Brown, Robert S., Jr. .
TRANSPLANTATION, 2013, 95 (07) :960-965
[4]   Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection [J].
Chemin, Isabelle ;
Guillaud, Olivier ;
Queyron, Philippe Chevallier ;
Trepo, Christian .
JOURNAL OF HEPATOLOGY, 2009, 51 (04) :824-825
[5]   Liver grafts from anti-hepatitis B core positive donors: A systematic review [J].
Cholongitas, Evangelos ;
Papatheodoridis, George V. ;
Burroughs, Andrew K. .
JOURNAL OF HEPATOLOGY, 2010, 52 (02) :272-279
[6]  
DANE DS, 1970, LANCET, V1, P695
[7]   HBV and the immune response [J].
Ferrari, Carlo .
LIVER INTERNATIONAL, 2015, 35 :121-128
[8]   Mechanisms of disease: Hepatitis B virus infection - Natural history and clinical consequences [J].
Ganem, D ;
Prince, AM .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (11) :1118-1129
[9]   Reactivation of Hepatitis B [J].
Hoofnagle, Jay H. .
HEPATOLOGY, 2009, 49 (05) :S156-S165
[10]   Solid Organ Transplantation From Hepatitis B Virus-Positive Donors: Consensus Guidelines for Recipient Management [J].
Huprikar, S. ;
Danziger-Isakov, L. ;
Ahn, J. ;
Naugler, S. ;
Blumberg, E. ;
Avery, R. K. ;
Koval, C. ;
Lease, E. D. ;
Pillai, A. ;
Doucette, K. E. ;
Levitsky, J. ;
Morris, M. I. ;
Lu, K. ;
McDermott, J. K. ;
Mone, T. ;
Orlowski, J. P. ;
Dadhania, D. M. ;
Abbott, K. ;
Horslen, S. ;
Laskin, B. L. ;
Mougdil, A. ;
Venkat, V. L. ;
Korenblat, K. ;
Kumar, V. ;
Grossi, P. ;
Bloom, R. D. ;
Brown, K. ;
Kotton, C. N. ;
Kumar, D. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2015, 15 (05) :1162-1172